Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ProPhase Labs (PRPH) Shares Outstanding (Diluted Average): 2011-2024

Historic Shares Outstanding (Diluted Average) for ProPhase Labs (PRPH) over the last 13 years, with Dec 2024 value amounting to $20.5 million.

  • ProPhase Labs' Shares Outstanding (Diluted Average) rose 117.73% to $41.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.5 million, marking a year-over-year increase of 117.73%. This contributed to the annual value of $20.5 million for FY2024, which is 18.92% up from last year.
  • ProPhase Labs' Shares Outstanding (Diluted Average) amounted to $20.5 million in FY2024, which was up 18.92% from $17.2 million recorded in FY2023.
  • In the past 5 years, ProPhase Labs' Shares Outstanding (Diluted Average) registered a high of $20.5 million during FY2024, and its lowest value of $11.6 million during FY2020.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $18.8 million, with a median of $18.7 million in 2022.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first spiked by 58.63% in 2021, then decreased by 7.74% in 2023.
  • Over the past 5 years, ProPhase Labs' Shares Outstanding (Diluted Average) (Yearly) stood at $11.6 million in 2020, then surged by 58.63% to $18.4 million in 2021, then increased by 1.40% to $18.7 million in 2022, then declined by 7.74% to $17.2 million in 2023, then climbed by 18.92% to $20.5 million in 2024.